Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages
Abstract The role of myeloid cells in the pathogenesis of SARS-CoV-2 is well established, in particular as drivers of cytokine production and systemic inflammation characteristic of severe COVID-19. However, the potential for myeloid cells to act as bona fide targets of productive SARS-CoV-2 infecti...
Saved in:
Main Authors: | Suzanne Pickering, Harry Wilson, Enrico Bravo, Marianne R. Perera, Jeffrey Seow, Carl Graham, Nathalia Almeida, Lazaros Fotopoulos, Thomas Williams, Atlanta Moitra, Helena Winstone, Tinne A. D. Nissen, Rui Pedro Galão, Luke B. Snell, Katie J. Doores, Michael H. Malim, Stuart J. D. Neil |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-54458-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative Prediction of Protein–Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV‑2 Spike Protein RBD
by: Lenard Neander, et al.
Published: (2025-01-01) -
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01) -
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
by: Denis N. Kisakov, et al.
Published: (2025-01-01) -
REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
by: Po-Chi Chan, et al.
Published: (2018-01-01) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
by: Lennox Chitsike, et al.
Published: (2021-01-01)